| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
10,101 |
8,902 |
$101K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
10,098 |
8,902 |
$88K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
7,013 |
6,552 |
$86K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
486 |
473 |
$53K |
| 87153 |
|
307 |
295 |
$10K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
67 |
57 |
$6K |
| 86780 |
|
1,838 |
1,717 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
433 |
326 |
$5K |
| 87503 |
|
166 |
164 |
$339.60 |
| 86592 |
|
116 |
86 |
$132.46 |
| 87077 |
|
15 |
13 |
$27.86 |